Literature DB >> 17146901

The moral implications of prenatal genetic testing.

Peter Chipman1.   

Abstract

The advance of medical technology now permits many genetic tests to be administered to a fetus in the womb. The goal of this testing is to determine the potential for genetically based disorders and disabilities. The use of these tests has major implications on the decision of a parent to abort a child based on what information they find in the prospective child's genes. Advocates of prenatal testing argue that it enables the families of these prospective children to make an informed decision when faced with the possibility of disability. I argue that this choice is drastically limited by social coercion through a discriminatory and stereotyped perception of the disabled community. Permitting an uncontrolled barrage of prenatal genetic tests will further promote the stereotype of a disabled life, and thus hinders our societal goal to recognise and promote equality and individuality. Which disabilities to test for, or what genes to search for, is a judgement that should be made only through extensive consultation with members of the disabled community, including individuals who have suffered from or who have been directly associated with the disability which is said to be tested.

Entities:  

Keywords:  Analytical Approach; Genetics and Reproduction

Mesh:

Year:  2006        PMID: 17146901

Source DB:  PubMed          Journal:  Penn Bioeth J


  3 in total

1.  Reproductive Decision Making and Genetic Predisposition to Sudden Cardiac Death.

Authors:  Dorit Barlevy; David Wasserman; Marina Stolerman; Kathleen E Erskine; Siobhan M Dolan
Journal:  AJOB Prim Res       Date:  2012-06-19

2.  Genetic screening services provided in Turkey.

Authors:  Yurdagül Erdem; Fulya Tekşen
Journal:  J Genet Couns       Date:  2013-09-18       Impact factor: 2.537

3.  Disability Experiences and Perspectives Regarding Reproductive Decisions, Parenting, and the Utility of Genetic Services: a Qualitative Study.

Authors:  C Roadhouse; C Shuman; K Anstey; K Sappleton; D Chitayat; E Ignagni
Journal:  J Genet Couns       Date:  2018-06-16       Impact factor: 2.537

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.